Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Initial studies attempted to address the relapse dilemma using genotyping data derived from 8-11 multiallelic markers, but statistical evaluations suggest that this approach was insufficient to achieve low errors in IBD [10,12].”
From Plasmodium vivax relapse reservoirs in Ethiopia: microhaplotype sequencing informs recurrent infection origins (2026) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, S. V., Trimarsanto, H., Amato, R., Murie, K., Taylor, A. R., Sutanto, E., Kleinecke, M., Whitton, G., Watson, J. A., Imwong, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51015-3 · Cited by 30
Self-citation
Research works printed but not linked: 64
- Robinson, 2015, Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model, PLoS Med., 12, 10.1371/journal.pmed.1001891 · DOI · Paper page
- Gruenberg, 2019, Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs, Sci. Rep., 9, 10.1038/s41598-019-54203-0 · doi:10.1038/s41598-019-54203-0
- Kleinecke, 2025, Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages, Nat. Commun., 16, 7192, 10.1038/s41467-025-62357-x · DOI · Paper page
- Lerch, 2017, Development of amplicon deep sequencing markers and data analysis pipeline for genotyping multi-clonal malaria infections, BMC Genom., 18, 864, 10.1186/s12864-017-4260-y · DOI
- Ruybal-Pesántez, 2024, Molecular markers for malaria genetic epidemiology: progress and pitfalls, Trends Parasitol., 40, 147, 10.1016/j.pt.2023.11.006 · DOI · Paper page
- Lerch, 2019, Longitudinal tracking and quantification of individual Plasmodium falciparum clones in complex infections, Sci. Rep., 9, 3333, 10.1038/s41598-019-39656-7 · DOI · Paper page
- Lin, 2015, Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse, J. Infect. Dis., 212, 999, 10.1093/infdis/jiv142 · DOI
- Wamae, 2022, Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 2; peer review: 1 approved, 1 approved with reservations], Wellcome Open Res., 7, 95, 10.12688/wellcomeopenres.17736.2 · doi:10.12688/wellcomeopenres.17736.2
- Jones, 2021, Should Deep-Sequenced Amplicons Become the New Gold Standard for Analyzing Malaria Drug Clinical Trials?, Antimicrob. Agents Chemother., 65, 10.1128/AAC.00437-21 · doi:10.1128/aac.00437-21
- He, 2021, Unraveling the Complexity of Imported Malaria Infections by Amplicon Deep Sequencing, Front. Cell. Infect. Microbiol., 11, 10.3389/fcimb.2021.725859 · DOI
- Wamae, 2022, Amplicon Sequencing as a Potential Surveillance Tool for Complexity of Infection and Drug Resistance Markers in Plasmodium falciparum Asymptomatic Infections, J. Infect. Dis., 226, 920, 10.1093/infdis/jiac144 · DOI · Paper page
- Holzschuh, 2024, Using a mobile nanopore sequencing lab for end-to-end genomic surveillance of Plasmodium falciparum: A feasibility study, PLOS Glob. Public Health, 4, 10.1371/journal.pgph.0002743 · DOI
- LaVerriere, 2022, Design and implementation of multiplexed amplicon sequencing panels to serve genomic epidemiology of infectious disease: A malaria case study, Mol. Ecol. Resour., 22, 2285, 10.1111/1755-0998.13622 · DOI
- Kattenberg, 2023, Molecular Surveillance of Malaria Using the PF AmpliSeq Custom Assay for Plasmodium falciparum Parasites from Dried Blood Spot DNA Isolates from Peru, Bio. Protoc., 13
- Kattenberg, 2023, Malaria Molecular Surveillance in the Peruvian Amazon with a Novel Highly Multiplexed Plasmodium falciparum AmpliSeq Assay, Microbiol. Spectr., 11, 10.1128/spectrum.00960-22 · DOI
- Talundzic, 2018, Next-generation sequencing and bioinformatics protocol for malaria drug resistance marker surveillance, Antimicrob. Agents Chemother., 62, e02474-17, 10.1128/AAC.02474-17 · DOI
- Huwe, 2022, Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh, Malar. J., 21, 218, 10.1186/s12936-022-04236-0 · DOI
- Wei, 2024, Genetic diversity of Plasmodium vivax population in northeast Myanmar assessed by amplicon sequencing of PvMSP1 and PvMSP3α, Acta Trop., 260, 10.1016/j.actatropica.2024.107461 · DOI
- Tapaopong, 2025, Molecular epidemiology and genetic diversity of disappearing Plasmodium vivax in southern Thailand, Sci. Rep., 15, 2620, 10.1038/s41598-025-86578-8 · DOI
- Reda, 2023, Amplicon deep sequencing of five highly polymorphic markers of Plasmodium falciparum reveals high parasite genetic diversity and moderate population structure in Ethiopia, Malar. J., 22, 376, 10.1186/s12936-023-04814-w · DOI
- Tapaopong, 2023, Genetic diversity and molecular evolution of Plasmodium vivax Duffy Binding Protein and Merozoite Surface Protein-1 in northwestern Thailand, Infect. Genet. Evol., 113, 10.1016/j.meegid.2023.105467 · doi:10.1016/j.meegid.2023.105467
- Holzschuh, 2023, Multiplexed ddPCR-amplicon sequencing reveals isolated Plasmodium falciparum populations amenable to local elimination in Zanzibar, Tanzania, Nat. Commun., 14, 3699, 10.1038/s41467-023-39417-1 · DOI
- Kattenberg, 2022, Novel highly-multiplexed AmpliSeq targeted assay for Plasmodium vivax genetic surveillance use cases at multiple geographical scales, Front. Cell. Infect. Microbiol., 12, 10.3389/fcimb.2022.953187 · DOI
- Kattenberg, 2024, Plasmodium vivax genomic surveillance in the Peruvian Amazon with Pv AmpliSeq assay, PLoS Negl. Trop. Dis., 18, 10.1371/journal.pntd.0011879 · DOI
- Popkin-Hall, 2024, High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes, Nat. Commun., 15, 10.1038/s41467-024-54731-y · DOI · Paper page
- Hubbard, 2025, PvGAP: Development of a globally-applicable, highly-multiplexed microhaplotype amplicon panel for Plasmodium vivax, medRxiv
- James, 2025, Efficacy of low-dose primaquine plus artemether-lumefantrine or dihydroartemisinin-piperaquine for radical cure of Plasmodium vivax in the Solomon Islands: a randomised clinical trial, Front. Malar., 3, 10.3389/fmala.2025.1604498 · DOI
- Rosado, 2021, Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts, PLoS Negl. Trop. Dis., 15, 10.1371/journal.pntd.0009165 · DOI
- Han, 2023, AmpSeqR: an R package for amplicon deep sequencing data analysis, F1000Res, 12, 327, 10.12688/f1000research.129581.1 · doi:10.12688/f1000research.129581.1
- Mideo, 2013, Ahead of the curve: next generation estimators of drug resistance in malaria infections, Trends Parasitol., 29, 321, 10.1016/j.pt.2013.05.004 · DOI
- Barry, 2015, Uncovering the transmission dynamics of Plasmodium vivax using population genetics, Pathog. Glob. Health, 109, 142, 10.1179/2047773215Y.0000000012 · doi:10.1179/2047773215y.0000000012
- Gerlovina, 2022, Dcifer: an IBD-based method to calculate genetic distance between polyclonal infections, Genetics, 222, 10.1093/genetics/iyac126 · DOI · Paper page
- Foo, 2026, Pv3Rs: Plasmodium vivax relapse, recrudescence, and reinfection statistical genetic inference, Bioinformatics, 42, 10.1093/bioinformatics/btaf643 · DOI · Paper page
- Rosas-Aguirre, 2021, Temporal and Microspatial Heterogeneity in Transmission Dynamics of Coendemic Plasmodium vivax and Plasmodium falciparum in Two Rural Cohort Populations in the Peruvian Amazon, J. Infect. Dis., 223, 1466, 10.1093/infdis/jiaa526 · DOI
- Manrique, 2019, Microsatellite analysis reveals connectivity among geographically distant transmission zones of Plasmodium vivax in the Peruvian Amazon: A critical barrier to regional malaria elimination, PLoS Negl. Trop. Dis., 13, 10.1371/journal.pntd.0007876 · DOI
- Imwong, 2012, The first Plasmodium vivax relapses of life are usually genetically homologous, J. Infect. Dis., 205, 680, 10.1093/infdis/jir806 · DOI · Paper page
- Chen, 2007, Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals, J. Infect. Dis., 195, 934, 10.1086/512242 · DOI · Paper page
- Noviyanti, 2022, Hypnozoite depletion in successive Plasmodium vivax relapses, PLoS Negl. Trop. Dis., 16, 10.1371/journal.pntd.0010648 · DOI
- Delgado-Ratto, 2014, Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon, Malar. J., 13, 8, 10.1186/1475-2875-13-8 · doi:10.1186/1475-2875-13-8
- Cowell, 2018, Exploration of Plasmodium vivax transmission dynamics and recurrent infections in the Peruvian Amazon using whole genome sequencing, Genome Med., 10, 52, 10.1186/s13073-018-0563-0 · DOI · Paper page
- Markus, 2012, Source of homologous parasites in recurrent Plasmodium vivax malaria, J. Infect. Dis., 206, 622, 10.1093/infdis/jis393 · doi:10.1093/infdis/jis393
- de Araujo, 2012, Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection, PLoS One, 7, 10.1371/journal.pone.0049871 · doi:10.1371/journal.pone.0049871
- Koepfli, 2013, A large Plasmodium vivax reservoir and little population structure in the South Pacific, PLoS One, 8, 10.1371/journal.pone.0066041 · DOI
- Gray, 2013, Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands, Malar. J., 12, 429, 10.1186/1475-2875-12-429 · DOI
- Popovici, 2018, Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia, mBio, 9, e01888-17, 10.1128/mBio.01888-17 · DOI
- Kho, 2021, Hidden biomass of intact malaria parasites in the human spleen, N. Engl. J. Med., 384, 2067, 10.1056/NEJMc2023884 · doi:10.1056/nejmc2023884
- Taylor, 2019, Resolving the cause of recurrent Plasmodium vivax malaria probabilistically, Nat. Commun., 10, 5595, 10.1038/s41467-019-13412-x · DOI · Paper page
- Hasugian, 2007, Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria, Clin. Infect. Dis., 44, 1067, 10.1086/512677 · DOI · Paper page
- Pukrittayakamee, 2008, Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria, Am. J. Trop. Med. Hyg., 79, 378, 10.4269/ajtmh.2008.79.378 · DOI
- Bousema, 2011, Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination, Clin. Microbiol. Rev., 24, 377, 10.1128/CMR.00051-10 · DOI · Paper page
- Bright, 2014, A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings, PLoS Negl. Trop. Dis., 8, 10.1371/journal.pntd.0002882 · DOI · Paper page
- Markus, 2017, Malaria eradication and the hidden parasite reservoir, Trends Parasitol., 33, 492, 10.1016/j.pt.2017.03.002 · doi:10.1016/j.pt.2017.03.002
- Oyola, 2016, Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification, Malar. J., 15, 597, 10.1186/s12936-016-1641-7 · doi:10.1186/s12936-016-1641-7
- Untergasser, 2012, Primer3--new capabilities and interfaces, Nucleic Acids Res., 40, 10.1093/nar/gks596 · DOI · Paper page
- Pagès, 2024, Biostrings: Efficient manipulation of biological strings, R package version, 2, 10
- Morgan, 2009, ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data, Bioinformatics, 25, 2607, 10.1093/bioinformatics/btp450 · DOI · Paper page
- Carrasco-Escobar, 2017, High prevalence of very-low Plasmodium falciparum and Plasmodium vivax parasitaemia carriers in the Peruvian Amazon: insights into local and occupational mobility-related transmission, Malar. J., 16, 415, 10.1186/s12936-017-2063-x · DOI
- Mangold, 2005, Real-time PCR for detection and identification of Plasmodium spp, J. Clin. Microbiol., 43, 2435, 10.1128/JCM.43.5.2435-2440.2005 · DOI · Paper page
- Rosanas-Urgell, 2010, Comparison of diagnostic methods for the detection and quantification of the four sympatric Plasmodium species in field samples from Papua New Guinea, Malar. J., 9, 361, 10.1186/1475-2875-9-361 · DOI · Paper page
- Pearson, 2016, Genomic analysis of local variation and recent evolution in Plasmodium vivax, Nat. Genet., 48, 959, 10.1038/ng.3599 · DOI · Paper page
- Li, 2009, The Sequence Alignment/Map format and SAMtools, Bioinformatics, 25, 2078, 10.1093/bioinformatics/btp352 · DOI · Paper page
- Havryliuk, 2009, A closer look at multiple-clone Plasmodium vivax infections: detection methods, prevalence and consequences, Mem. Inst. Oswaldo Cruz, 104, 67, 10.1590/S0074-02762009000100011 · DOI
- White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malar. J., 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page
- White, 2021, Anti-malarial drug effects on parasite dynamics in vivax malaria, Malar. J., 20, 161, 10.1186/s12936-021-03700-7 · DOI
Cited by
Degaga, T. S., Sime, H., Ruybal-Pesántez, S., Osborne, A., Mwaura, M., Bamboro, S. A., Mnjala, H., Mekonnen, G., Ermias, S., Fantahun, A., et al. (2026) · Malaria Journal · doi:10.1186/s12936-026-06050-4 · Cited by 1
Self-citationOsborne, A. A., Ruybal-Pesantez, S., Rai, A., Trimarsanto, H., Hoon, K. S., Piera, K., Kleinecke, M., Rumaseb, A., Sutanto, E., Thriemer, K., et al. (2026) · doi:10.64898/2026.11.12.765293
Self-citation
Metadata
- Authors
- Rosado, J., Han, J., Obadia, T., Munro, J., Traore, Z., Schoffer, K., Brewster, J., Bourke, C., Vinetz, J. M., Taylor, A. R., White, M., Bahlo, M., Gamboa, D., Mueller, I., & Ruybal-Pesántez, S.
- ORCID
- Rosado, Jason
- Venue
- iScience
- Publisher
- Elsevier BV
- Published
- 2026-05
- Volume
- 29
- Issue
- 5
- Pages
- 115799
- ISSN
- 2589-0042
- Cited by
- 3
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Institut Pasteur
- Institut de Recherche pour le Développement
- French National Research Agency (ANR-10-LABX-62-IBEID, ANR-16-CONV-0005)
- Mackay Regional Council (MR/X020258/1)
- Ahvaz Jundishapur University of Medical Sciences Infectious and Tropical Diseases Research Center (GNT1195236)
- European Research Executive Agency
- U.S. Public Health Service
- National Institutes of Health
- Australian Centre of Research Excellence in Malaria Elimination
- Medical Research Council
- Research Executive Agency
- European Commission (101110393)
- National Health and Medical Research Council (2016726)
- National Institutes of Health Fogarty International Center (2D43TW007120-11A1)
- Gates Foundation (OPP1151132)
- National Institute of Allergy and Infectious Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification. https://app.cochat.ai/papers/10.1016/j.isci.2026.115799
- The paper
- Rosado, J., Han, J., Obadia, T., Munro, J., Traore, Z., Schoffer, K., Brewster, J., Bourke, C., Vinetz, J. M., Taylor, A. R., White, M., Bahlo, M., Gamboa, D., Mueller, I., & Ruybal-Pesántez, S. (2026). Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification. iScience. https://doi.org/10.1016/j.isci.2026.115799
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.